Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.
Mbongo
N
N
Centre National de la Recherche Scientifique, Institute de Chimie des Substances Naturelles, Gif sur Yvette, France.
Loiseau
P M
PM
Craciunescu
D G
DG
Robert-Gero
M
M
D000666:Amphotericin B / Q000494:pharmacology*; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D007495:Iridium / Q000494:pharmacology*; D007893:Leishmania donovani / Q000187:drug effects*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000469:parasitology; D008264:Macrophages / Q000469:parasitology; D051379:Mice; D008807:Mice, Inbred BALB C; D009942:Organometallic Compounds / Q000494:pharmacology*; D010303:Paromomycin / Q000494:pharmacology*; D010419:Pentamidine / Q000494:pharmacology* / Q000627:therapeutic use; D011897:Random Allocation
D000981:Antiprotozoal Agents; C114662:Ir-(1,3-1,5-cyclooctatetrane)-pentamidine alizarin red; D009942:Organometallic Compounds; D007495:Iridium; D010303:Paromomycin; D010419:Pentamidine; D000666:Amphotericin B